Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Isao Miyazaki
Observed names:
I Miyazaki,
I. MIYAZAKI,
I. Miyazaki,
Isao MIYAZAKI,
Miyazaki, I.
Institution:
Taiho Pharmaceutical (Japan)
Observed institutions:
Tokyo University of Science,
University of Toronto,
Kyorin University,
Hospital for Sick Children,
RIKEN,
Taiho Pharmaceutical (Japan),
Taiho Oncology (United States),
RIKEN Advanced Science Institute,
Kyorin University Hospital
show all 9
ORCID:
0009-0008-3742-1243
Observed ORCID:
0009-0008-3742-1243
OpenAlex ID:
A5060177022
Diagnosis of Nasopharyngeal Carcinoma by DNA Amplification of Tissue Obtained by Fine-Needle Aspiration
1992
·
Raphael Feinmesser
, Isao Miyazaki
, et al.
·
New England Journal of Medicine
·
144
PDF
Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.
1993
·
I Miyazaki
, R K Cheung
, et al.
·
The Journal of Experimental Medicine
·
143
PDF
A small-molecule inhibitor shows that pirin regulates migration of melanoma cells
2010
·
Isao Miyazaki
, Siro Simizu
, et al.
·
Nature Chemical Biology
·
115
Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
2014
·
E. Higashihara
, K. Nutahara
, et al.
·
Nephrology Dialysis Transplantation
·
66
PDF
T cell activation and anergy to islet cell antigen in type I diabetes.
1995
·
I Miyazaki
, R K Cheung
, et al.
·
The Journal of Immunology
·
53
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
2023
·
Isao Miyazaki
, Igor Odintsov
, et al.
·
Nature Cancer
·
48
PDF
Kidney Volume Estimations with Ellipsoid Equations by Magnetic Resonance Imaging in Autosomal Dominant Polycystic Kidney Disease
2015
·
Eiji Higashihara
, Kikuo Nutahara
, et al.
·
The Nephron journals/Nephron journals
·
44
PDF
Robust and Systematic Drug Screening Method Using Chemical Arrays and the Protein Library: Identification of Novel Inhibitors of Carbonic Anhydrase II
2008
·
Isao MIYAZAKI
, Siro SIMIZU
, et al.
·
Bioscience Biotechnology and Biochemistry
·
40
Epstein-barr Virus Surveillance After Renal Transplantation
1994
·
Charles H. Crompton
, Roy K. Cheung
, et al.
·
Transplantation
·
36
Cloning of humna and rat p69 cDNA, a candidate autoimmune target in type 1 diabetes
1994
·
Isao Miyazaki
, Roger Gaedigk
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
30
Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease
2017
·
Hiroki Yoshida
, Eiji Higashihara
, et al.
·
Acta Neurochirurgica
·
18
Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases
2018
·
Eiji Higashihara
, Kouji Yamamoto
, et al.
·
Clinical and Experimental Nephrology
·
16
PDF
Estimation of Changes in Kidney Volume Growth Rate in ADPKD
2020
·
Eiji Higashihara
, Hiroshi Fukuhara
, et al.
·
Kidney International Reports
·
14
PDF
Structure–Affinity Relationship Study of Bleomycins and Shble Protein by Use of a Chemical Array
2009
·
Isao Miyazaki
, Hideo Okumura
, et al.
·
ChemBioChem
·
14
Unexpected patterns of Epstein—Barr virus gene expression during early stages of B cell transformation
1993
·
Roy K. Cheung
, Isao Miyazaki
, et al.
·
International Immunology
·
14
Abstract P06-02: Discovery of TAS0953/HM06, a novel next generation RET-specific inhibitor capable of inhibiting RET solvent front mutations
2021
·
Isao Miyazaki
, Keiji Ishida
, et al.
·
Molecular Cancer Therapeutics
·
11
A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
2017
·
Eiji Higashihara
, Shigeo Horie
, et al.
·
Clinical and Experimental Nephrology
·
11
PDF
On‐Chip Fragment‐Based Approach for Discovery of High‐Affinity Bivalent Inhibitors
2009
·
Isao Miyazaki
, Siro Simizu
, et al.
·
ChemBioChem
·
11
Preclinical evaluation of targeted therapies for central nervous system metastases
2024
·
Alexander J. Pfeil
, Joshua D. Hale
, et al.
·
Disease Models & Mechanisms
·
10
PDF
Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.
2022
·
Igor Odintsov
, Allan J.W. Lui
, et al.
·
Journal of Clinical Oncology
·
8
Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan
2014
·
Eiji Higashihara
, Kikuo Nutahara
, et al.
·
Clinical and Experimental Nephrology
·
8
The Application of the Chemical Array for Biological Study
2010
·
Isao Miyazaki
, Siro Simizu
, et al.
·
Methods in molecular biology
·
8
The role of vIL-10 and other EBV latency genes early during B cell growth transformation
1994
·
Isao Miyazaki
, Roy K. Cheung
, et al.
·
Seminars in Virology
·
6
Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan
2018
·
Tsuyoshi Yamaguchi
, Eiji Higashihara
, et al.
·
Clinical and Experimental Nephrology
·
5
Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
2023
·
Toshihiro Shibutani
, Risa Goto
, et al.
·
Scientific Reports
·
3
PDF
Show more works
View as search
Works count:
46
Citation count:
883
H-index:
14
I10-index:
19
Year
Topic
Type